Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
filingDate |
2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_112b8ae7ff04f2b7cebff63ddf50f349 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f570508f4b33ee6d7f7e01ff6c10dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9f36d7b94dba98bb1216cc4cd6e750 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68cc54f36dad87181f3e3d3f1c39c25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da64e500b7371a574d897d938309e1f |
publicationDate |
2015-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015087641-A1 |
titleOfInvention |
Heterocyclic cgrp receptor antagonists |
abstract |
The present invention is directed to heterocyclic compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. |
priorityDate |
2012-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |